MedTrace Logo

Biomarkers of Atrial Fibrillation Complicated With Stroke Based on Proteomics and Metabolomics

NCT05181787 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-01-25

No results posted yet for this study

Summary

Thrombus shedding in patients with atrial fibrillation (AF) can lead to cerebral artery embolism. Stroke caused by AF is very dangerous, which not only threatens the life of patients, but also seriously affects the quality of life. This study aims to explore the biomarkers of stroke in patients with AF by integrating proteomics and metabolomics data, and establish the network relationship of stroke in patients with AF, so as to reveal the molecular mechanism of stroke in patients with AF.

Conditions

Interventions

DIAGNOSTIC_TEST

Proteomics

Proteomic data were obtained by LC-MS/MS Analysis-DIA platform.

DIAGNOSTIC_TEST

Metabolomics

Metabolomic data were obtained by UPLC-QTOF/MS platform.

Sponsors & Collaborators

  • Yue LI

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-20
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05181787 on ClinicalTrials.gov